X
ABMD

Xponance’s Abiomed Inc ABMD Stock Holding History

Xponance’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-9,359
Closed -$2.3M – 1251
2022
Q3 		$2.3M Buy
9,359
+642
+7% +$173K 0.04% 353
2022
Q2 		$2.16M Buy
8,717
+1,200
+16% +$324K 0.04% 356
2022
Q1 		$2.49M Buy
7,517
+129
+2% +$39.7K 0.04% 323
2021
Q4 		$2.65M Buy
7,388
+547
+8% +$185K 0.04% 317
2021
Q3 		$2.23M Sell
6,841
-195
-3% -$66.1K 0.04% 328
2021
Q2 		$2.2M Buy
7,036
+512
+8% +$157K 0.04% 349
2021
Q1 		$2.08M Sell
6,524
-12
-0.2% -$3.84K 0.04% 310
2020
Q4 		$2.12M Buy
6,536
+93
+1% +$25.7K 0.05% 306
2020
Q3 		$1.78M Buy
6,443
+44
+0.7% +$12.7K 0.04% 307
2020
Q2 		$1.55M Buy
+6,399
New +$1.28M 0.04% 302

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Xponance's ABMD Position: Q4 2022 in Review

Xponance sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 9,359 shares — an estimated $2.3M sold.

Xponance first reported a position in ABMD in Q2 2020 and held it in 10 quarters. The position peaked at $2.65M in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Xponance reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Xponance sold 9,359 Abiomed Inc shares in Q4 2022, an estimated $2.3M.
  • Xponance first reported a position in Abiomed Inc in Q2 2020 and held it in 10 quarters.
  • Xponance's Abiomed Inc position peaked at $2.65M in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Xponance's 13F filing for Q4 2022, filed 24 Jan 2023.